Dr. Douglas Vaughn Schultz

D.D.S. | Dentist



  
  330 N Sangamon Ave, Gibson City
  Illinois, 60936-1256

  217-784-5133    217-784-8460 Maps & Directions
Dr. Douglas Vaughn Schultz is a Gibson City, Illinois based Dentist who is specialized in General Practice Dentistry. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. His current practice location is 330 N Sangamon Ave, Gibson City. Patients can reach him at 217-784-5133.
Dr. Douglas Vaughn Schultz is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Douglas Vaughn Schultz speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Douglas Vaughn Schultz
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:No
Practice Address:330 N Sangamon Ave, Gibson City,
Illinois, 60936-1256
Phone:217-784-5133
Fax:217-784-8460
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1992714349
NPI Enumeration Date: 05 Aug, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 330 N Sangamon Ave,
Gibson City, Illinois
Zip: 60936-1256
Phone Number: 217-784-5133
Fax Number: 217-784-8460
Patients can reach Dr. Douglas Vaughn Schultz at 330 N Sangamon Ave, Gibson City, Illinois or can call to book an appointment on 217-784-5133. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: